DrugPatentWatch Database PreviewSee Plans and Pricing
« Back to Dashboard
Small Molecule Drugs cited in ASTRAZENECA AB v. MYLAN PHARMACEUTICALS INC.
|Date Filed||Document No.||Description||Snippet||Link To Document|
|2016-01-12||40||U.S. Patent Nos. 5,712,298, 8,536,206, 8,604,064, and 8,618,142 (collectively, the “Patents-in-Suit…Act for a drug claimed in a patent or the use of which is claimed in a patent[.]” …collectively, “Plaintiffs”), bring this Hatch-Waxman Act patent infringement suit against Defendant Mylan Pharmaceuticals…Dalisresp, and that Defendant will infringe the Patents-in-Suit pursuant to 35 U.S.C. § 271(a), (b), and…litigates in this district, having been a party to 41 patent infringement cases since 2010, the majority of||External link to document|
|>Date Filed||>Document No.||>Description||>Snippet||>Link To Document|